5:59 MGMT181 - Spring 2022: IndivAssign03 Read the case study "Astrazeneca - Fighting a Global Pandemic". Complete this Individual Assignment in your own words, and using your own research. Describe how Outlook on the Web should be used in a project such as the one described in the case study. What Megatrends can you find in the case study? As a project manager how do these megatrends affect you? Create a SWOT diagram and analysis based on the case study. Write a concise paragraph describing your analysis. Would a scoring model be useful in interpreting this case? If so, how would it be useful? If not, why not? If you had to give a presentation to your Vice-President (assume you are working as a Project Manager at this company) about the contents of this case study, how would you use Excel as a tool to aid in your presentation? What communication tool would be the most effective in your presentation to the Vice-President? (hint: refer to IndivAssign02 for a list of possible communication tools) Explain why your chosen communication tool would be relevant in this situation. 7 What aspect of Emotional Intelligence would you use the most if you had to interact with the staff of AstraZeneca as depicted in the case study? Why would you choose this aspect of EI? 8 Would any aspect of Agile be useful in this case study? Explain why or why not? Requirements: A professional document in pdf format. fleming.desire2learn.com5:59 '3" Project ' Management 1& Institute. ASTRAZENECA Fighting a Global Pandemic CHALLENGE: From Lab to Jab at Light Speed As COVID-19 spread throughout the world in the spring of 2020, AstraZeneca recognized the need for an effective COVlD-19 vaccine to defeat the virus. In April 2020 AstraZeneca joined forces with the University of Oxford to make a meaningful difference and save lives. This landmark partnership brought together world-class expertise in vaccinology with AstraZeneca's ability to deliver a global solution at scale. AstraZeneca's research partners at Oxford University had demonstrated an immune response in preclinical studies and some encouraging early clinical results that provided a basis for confidence that a vaccine could be rapidly developed. AstraZeneca's proven manufacturing capability and global supply chain would enable rapid progress from the research lab to the development of a highly effective vaccine, with a favorable safety profile that could be administered around the world. AstraZeneca and Oxford University pledged to provide the vaccine on a not-for-prot basis. This commitmentto broad and equitable access ensured that the vaccine would be available at cost during the pandemic, and accessible to low-income countries after the pandemic subsides. To be successful. however. AstraZeneca would have to make every dollar count. Pro 1'. PD! Mangement IR . Institute. CONTEXT: Risk, Complexity, and Visibility AstraZeneca is a global blo- pharmaceutical company headquartered in Cambridge, England, with revenues of $26.6 billion (2020). Key Results As of July 2021, AstraZeneca has released 1 billion doses for supply to 170 countries. From the moment AstraZeneca publicly announced a vaccine partnership with Oxford University on April 30, 2020, the process it undertook was unlike that for any other technology it had developed in the past. with vastly more uncertainty, complexity, and visibility. fleming.desire2learn.com